We are live on
!
Find out more
H
HoyleCohen Portfolio holdings
AUM
$1.32B
1-Year Est. Return
27.05%
This Fund
S&P 500
This Quarter
Est. Return
+8.57%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$1B
AUM Growth
+$91.5M
(+10%)
Cap. Flow
+$37.7M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
29.49%
Holding
273
New
16
Increased
96
Reduced
114
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Group Global Growth Equity ETF
CGGO
|
+$17.7M |
| 2 |
Capital Group Growth ETF
CGGR
|
+$10.2M |
| 3 |
Capital Group Dividend Value ETF
CGDV
|
+$5.78M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$2.3M |
| 5 |
Vanguard Value ETF
VTV
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.09M |
| 2 |
Applied Materials
AMAT
|
+$1.13M |
| 3 |
Microsoft
MSFT
|
+$1.04M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$843K |
| 5 |
Vanguard Total World Stock ETF
VT
|
+$786K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Financials | 11.86% |
| 3 | Healthcare | 10.01% |
| 4 | Industrials | 6.6% |
| 5 | Energy | 6.09% |
Similar funds
PRIG
HIG
PO
BPCA
GP
AT
KI
CDH
HoyleCohen's Q4 2022 Portfolio in Review
As of Q4 2022, HoyleCohen held 273 positions worth $1B, up 10% from $913M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
HoyleCohen deployed $37.7M of net new capital in Q4 2022, opening 16 new positions and adding to 96 existing holdings. Its largest new stake was Capital Group Dividend Value ETF: 252,037 shares worth $5.95M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was AbbVie, an estimated $2.09M trimmed.
- HoyleCohen's largest Q4 2022 buy was Capital Group Dividend Value ETF: 252,037 shares worth $5.95M.
- HoyleCohen added most to Capital Group Global Growth Equity ETF in Q4 2022, an estimated $17.7M increase.
- HoyleCohen's biggest Q4 2022 reduction was AbbVie, cutting an estimated $2.09M.
- HoyleCohen fully exited iShares S&P Small-Cap 600 Value ETF in Q4 2022, selling an estimated $398K.
- HoyleCohen's ten largest holdings make up 29% of its $1B portfolio in Q4 2022.
- HoyleCohen opened 16 new positions and closed 9 in Q4 2022.
- HoyleCohen's portfolio value rose 10% quarter-over-quarter to $1B.
Based on HoyleCohen's 13F filing for Q4 2022, filed 14 Feb 2023.